Answers are grounded in this paper and cite their sources.
Hypereosinophilic syndrome (HES) is defined as hypereosinophilia due to any cause (absolute eosinophil count > 1500 cells/μL) in the peripheral blood, which leads to eosinophil-mediated multiorgan damage. Cardiac involvement is a significant cause of morbidity and mortality among patients with HES. Here, we discuss a case of eosinophilia-related endomyocardial involvement, also known as Loeffler’s endocarditis, a rare form of restrictive cardiomyopathy. Notably, on genetic analysis, he was found to have a rare FIP1-like-1-platelet-derived growth factor receptor alpha-associated myeloproliferative variant of HES, which responded to imatinib, making it one of the very few reported cases of such kind.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: